Dataset from A Phase 3, Open-label, Multicenter, Long-term Study to Evaluate the Safety, Efficacy and Pharmacokinetics of TAK-536 in Pediatric Patients 6 to Less Than 16 Years of Age With Hypertension
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007571
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety of administration of azilsartan in
pediatric patients aged 6 to less than 16 years with hypertension.
创建时间：
2025-10-01
